You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

Midazolam hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for midazolam hydrochloride and what is the scope of patent protection?

Midazolam hydrochloride is the generic ingredient in six branded drugs marketed by Apothecon, Baxter Hlthcare Corp, Bedford, Ben Venue, Endo Operations, Epic Pharma Llc, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Hospira Inc, Igi Labs Inc, Intl Medicated, Intl Medication, Micro Labs, Rising, Steriscience Speclts, HLR, Rafa Labs Ltd, MMT, Padagis Us, Pai Holdings, Pharm Assoc, Sun Pharm Inds Ltd, and Roche, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.

Twenty-five suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for midazolam hydrochloride
US Patents:0
Tradenames:6
Applicants:25
NDAs:40
Finished Product Suppliers / Packagers: 25
Raw Ingredient (Bulk) Api Vendors: 36
Clinical Trials: 1,499
Patent Applications: 1,566
What excipients (inactive ingredients) are in midazolam hydrochloride?midazolam hydrochloride excipients list
DailyMed Link:midazolam hydrochloride at DailyMed
Recent Clinical Trials for midazolam hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Alabama at BirminghamPhase 1
Medical University of South CarolinaPhase 4
Ruijin HospitalPhase 1/Phase 2

See all midazolam hydrochloride clinical trials

Generic filers with tentative approvals for MIDAZOLAM HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign UpEQ 5MG BASE/MLINJECTABLE;INJECTION

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for midazolam hydrochloride
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for midazolam hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for midazolam hydrochloride

US Patents and Regulatory Information for midazolam hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Steriscience Speclts MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE midazolam hydrochloride INJECTABLE;INJECTION 090315-002 Nov 29, 2010 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075243-002 Jun 20, 2000 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 212847-002 Dec 11, 2020 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075856-002 Jun 13, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for midazolam hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hlr VERSED midazolam hydrochloride INJECTABLE;INJECTION 018654-002 May 26, 1987 ⤷  Sign Up ⤷  Sign Up
Roche VERSED midazolam hydrochloride SYRUP;ORAL 020942-001 Oct 15, 1998 ⤷  Sign Up ⤷  Sign Up
Hlr VERSED midazolam hydrochloride INJECTABLE;INJECTION 018654-001 Dec 20, 1985 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.